FR2362839A1 - Derives de l'hydantoine et medicaments contenant ces substances - Google Patents

Derives de l'hydantoine et medicaments contenant ces substances

Info

Publication number
FR2362839A1
FR2362839A1 FR7716849A FR7716849A FR2362839A1 FR 2362839 A1 FR2362839 A1 FR 2362839A1 FR 7716849 A FR7716849 A FR 7716849A FR 7716849 A FR7716849 A FR 7716849A FR 2362839 A1 FR2362839 A1 FR 2362839A1
Authority
FR
France
Prior art keywords
substances
hydantoin derivatives
products containing
medicinal products
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7716849A
Other languages
English (en)
Other versions
FR2362839B1 (fr
Inventor
Albert Gordon Caldwell
Norman Whittaker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2362839A1 publication Critical patent/FR2362839A1/fr
Application granted granted Critical
Publication of FR2362839B1 publication Critical patent/FR2362839B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin

Abstract

Nouveaux dérivés de l'hydantoïne. Ils sont caractérisés par la formule générale :
FR7716849A 1976-06-03 1977-06-02 Derives de l'hydantoine et medicaments contenant ces substances Granted FR2362839A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2287776 1976-06-03
GB5034076 1976-12-02
GB1214577 1977-03-23

Publications (2)

Publication Number Publication Date
FR2362839A1 true FR2362839A1 (fr) 1978-03-24
FR2362839B1 FR2362839B1 (fr) 1980-02-01

Family

ID=27256793

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7716849A Granted FR2362839A1 (fr) 1976-06-03 1977-06-02 Derives de l'hydantoine et medicaments contenant ces substances

Country Status (12)

Country Link
JP (1) JPS52151168A (fr)
CA (1) CA1176261A (fr)
CH (3) CH645631A5 (fr)
DE (1) DE2724948A1 (fr)
DK (1) DK244577A (fr)
ES (5) ES459412A1 (fr)
FI (1) FI71930C (fr)
FR (1) FR2362839A1 (fr)
HU (1) HU183046B (fr)
NL (1) NL7706064A (fr)
NZ (1) NZ184281A (fr)
SE (2) SE446336B (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0001238A1 (fr) * 1977-09-05 1979-04-04 The Wellcome Foundation Limited Dérivés de l'hydantoine, procédés de préparation, leurs compositions pharmaceutiques et leurs intermédiaires
EP0002259A2 (fr) * 1977-12-01 1979-06-13 The Wellcome Foundation Limited Dérivés de l'hydantoine et leurs sels, leur synthèse et leurs compositions pharmaceutiques
EP0002258A2 (fr) * 1977-12-01 1979-06-13 The Wellcome Foundation Limited Dérivés de l'hydantoine et leurs sels, leur synthèse et intermédiaires, leurs compositions pharmaceutiques
FR2427331A2 (fr) * 1978-05-31 1979-12-28 Wellcome Found Derives de l'hydantoine et medicaments contenant ces substances
EP0014076A2 (fr) * 1979-01-18 1980-08-06 Beecham Group Plc Dérivés d'hydantoine, leur préparation et compositions pharmaceutiques

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2963795D1 (en) * 1978-01-23 1982-11-11 Beecham Group Plc Hydantoins and thiohydantoins, method for their preparation and pharmaceutical compositions containing them
EP0004723A1 (fr) * 1978-03-30 1979-10-17 Beecham Group Plc Déoxyhydantoines, leurs procédés de préparation et compositions pharmaceutiques les contenant
EP0006352A1 (fr) * 1978-06-15 1980-01-09 Beecham Group Plc Hydantoines et thiohydantoines, procédé pour leur préparation et compositions pharmaceutiques les contenant
IL57504A0 (en) * 1978-06-15 1979-10-31 Beecham Group Ltd Prostagandin analogues,their preparation and pharmaceutical compositions containing
DE2965099D1 (en) * 1978-06-15 1983-05-05 Beecham Group Plc Prostaglandin analogue triazole derivatives, processes for their preparation and a pharmaceutical composition containing them
AU4778279A (en) * 1978-06-15 1979-12-20 Beecham Group Limited Prostaglandin analogues
EP0019223A1 (fr) * 1979-05-09 1980-11-26 The Wellcome Foundation Limited Dérivés d'hydantoine optiquement actifs, leur préparation, compositions pharmaceutiques les contenant, et intermédiaires
US4684735A (en) * 1985-07-01 1987-08-04 Stauffer Chemical Company Promotion of raney nickel hydrogenation catalyst
JP3022878U (ja) * 1995-08-18 1996-04-02 有限会社春江加工 ミニディスク用ケース
PL370515A1 (en) * 2001-11-30 2005-05-30 Eli Lilly And Company Peroxisome proliferator activated receptor agonists
AU2004245122A1 (en) * 2003-06-06 2004-12-16 Allergan, Inc. Piperidinyl prostaglandin E analogs
US7179820B2 (en) * 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524818A (en) * 1974-11-29 1978-09-13 Beecham Group Ltd 12-azaprostaglandins

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0001238A1 (fr) * 1977-09-05 1979-04-04 The Wellcome Foundation Limited Dérivés de l'hydantoine, procédés de préparation, leurs compositions pharmaceutiques et leurs intermédiaires
EP0002259A2 (fr) * 1977-12-01 1979-06-13 The Wellcome Foundation Limited Dérivés de l'hydantoine et leurs sels, leur synthèse et leurs compositions pharmaceutiques
EP0002258A2 (fr) * 1977-12-01 1979-06-13 The Wellcome Foundation Limited Dérivés de l'hydantoine et leurs sels, leur synthèse et intermédiaires, leurs compositions pharmaceutiques
EP0002259A3 (en) * 1977-12-01 1979-06-27 The Wellcome Foundation Limited Hydantoin derivatives and salts thereof, their synthesis and intermediates, and pharmaceutical formulations
EP0002258A3 (en) * 1977-12-01 1979-06-27 The Wellcome Foundation Limited Hydantoin derivatives and salts thereof, their synthesis and intermediates, and pharmaceutical formulations
US4337262A (en) * 1977-12-01 1982-06-29 Burroughs Wellcome Co. Hydantoin derivatives, pharmaceutical compounds and methods of use
FR2427331A2 (fr) * 1978-05-31 1979-12-28 Wellcome Found Derives de l'hydantoine et medicaments contenant ces substances
EP0014076A2 (fr) * 1979-01-18 1980-08-06 Beecham Group Plc Dérivés d'hydantoine, leur préparation et compositions pharmaceutiques
EP0014076A3 (en) * 1979-01-18 1980-09-17 Beecham Group Limited Hydantoin derivatives, their preparation and pharmaceutical compositions

Also Published As

Publication number Publication date
CH645631A5 (en) 1984-10-15
CH647511A5 (en) 1985-01-31
FI771763A (fi) 1977-12-04
JPS6222986B2 (fr) 1987-05-20
SE7706428L (sv) 1977-12-04
CH646426A5 (en) 1984-11-30
ES8103057A1 (es) 1981-02-16
ES482010A1 (es) 1980-08-16
FI71930C (fi) 1987-03-09
SE8203161L (sv) 1982-05-19
HU183046B (en) 1984-04-28
JPS52151168A (en) 1977-12-15
ES470428A1 (es) 1979-09-01
NZ184281A (en) 1980-04-28
ES478156A1 (es) 1979-11-01
ES459412A1 (es) 1978-11-01
DK244577A (da) 1977-12-04
CA1176261A (fr) 1984-10-16
DE2724948A1 (de) 1977-12-15
ES489883A0 (es) 1981-02-16
FI71930B (fi) 1986-11-28
SE446336B (sv) 1986-09-01
FR2362839B1 (fr) 1980-02-01
NL7706064A (nl) 1977-12-06

Similar Documents

Publication Publication Date Title
FR2362839A1 (fr) Derives de l'hydantoine et medicaments contenant ces substances
BE777689A (fr) Nouveaux derives de l'imidazoline, compositions therapeutiques les contenant ainsi que le procede de preparation de ces derives et de ces compositions
FR2392971A1 (fr) Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances
FR2429593A1 (fr) Medicaments contenant des derives d'imidazole
BE829837A (fr) Nouveaux derives du benzothiophene, leurs procedes de preparation ainsi que les compositions pharmaceutiques les contenant
FR2300083A1 (fr) Derives d'hydantoine 1,5-alcoyl
BE887970A (fr) Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
FR2370732A1 (fr) Derives polysubstitues de la piperidine, leurs procedes de preparation et leur application en tant que medicaments
FR2358385A1 (fr) Derives de l'anilide benzoique et fongicides contenant ces derives
BE848496A (fr) Derives d'amino-alcools, leur preparation et utilisation, ainsi que compositions contenant ces derives.
FR2433512A1 (fr) Derives de l'indane et medicaments qui en contiennent
BE857138A (fr) Derives peptidiques, procede pour leur preparation et compositions therapeutiques contenant ces composes
KR910021361A (ko) 항궤양 물질
FR2324608A1 (fr) Derives de l'hydroxy-4 cyclopentene-2-one-1 utilisables pour la fabrication de medicaments, et preparation de ces substances
FR2355021A1 (fr) Nouveaux derives d'imidazothiazine et leur application en tant que medicaments
FR2356643A1 (fr) 5-0-acyl-imidazole-4-carboxamides, leur obtention et composition pharmaceutique en contenant
FR2361361A1 (fr) Nouveaux derives du cyclopentane et medicaments contenant ces substances
BE830577A (fr) Derives actifs d'acide acetique, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions
FR2427331A2 (fr) Derives de l'hydantoine et medicaments contenant ces substances
BE860162A (fr) Derives actifs de l'uree leur procede de preparation ainsi que les compositions therapeutiques les contenant
IT7950049A0 (it) Derivati acetilenici dell'androst-4-ene,procedimento per la loro produzione,loro impiego come medicamenti e composizioni farmaceutiche che licontengono
BE884171A (fr) Nouveaux derives de l'ergol-8-ene et de l'ergoline, procede de preparation de ces derives et medicaments les contenant
BE826711A (fr) Derives d'indolylacetylamino-acide, leur procede de preparation et les compositions pharmaceutiques contenant ces composes
BE884716A (fr) Derives du 1,1,2-triphenylpropane et du 1,1,2-triphenylpropene procede de preparation de ces derives et compositions pharmaceutiques contenant ces nouveaux composes

Legal Events

Date Code Title Description
ST Notification of lapse